Gender differences in sympathetic nervous activity: influence of body mass and blood pressure

Background Obesity and high blood pressure (BP) commonly coexist in patients, and both conditions are associated with elevated sympathetic nervous activity. We tested whether the sympathetic nervous system was differently affected in men and women by the body mass index (BMI), BP, leptin and weight loss. Methods We measured muscle sympathetic nerve activity (MSNA, microneurography), BP and plasma leptin concentrations in 167 age-matched normotensive and hypertensive men and women divided into three subgroups: lean, BMI < 25 kg/m2; overweight, BMI ≥ 25 and < 30 kg/m2; and obese, BMI ≥ 30 kg/m2. These measurements were repeated in a subgroup of 19 obese subjects who underwent a 12-week diet. Results Women with hypertension had increased MSNA compared with their normotensive counterparts (37 ± 2 versus 25 ± 2 bursts/min, analysis of variance, P < 0.001) and MSNA was significantly related to BP (P < 0.05, r2 = 0.236) but not to BMI. MSNA in men with hypertension was no different from that in normotensive subjects (33 ± 2 versus 30 ± 2 bursts/min), but MSNA was significantly related to BMI (P < 0.05, r2 = 0.249). Diet resulted in the same degree of weight loss in men and women, but induced a decrease in MSNA only in men (43 ± 3 to 34 ± 3 bursts/min, P < 0.01). The plasma leptin concentration was higher in women than in men, and for both groups it was related to BMI not BP (r2 = 0.497, P < 0.001 in women and r2 = 0.483, P < 0.001 in men). Conclusion These data demonstrate a gender difference in the regulation of the sympathetic nervous system, in which MSNA mainly relates to BP in women and to BMI in men.

[1]  Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation , 2006, Endocrine.

[2]  Elisabeth Lambert,et al.  Mechanisms of sympathetic activation in obesity-related hypertension. , 2006, Hypertension.

[3]  T. Ogihara,et al.  Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. , 2006, American journal of hypertension.

[4]  P. Nestel,et al.  Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  W. Haynes.  Role of leptin in obesity‐related hypertension , 2005, Experimental physiology.

[6]  V. Somers,et al.  Gender-Selective Interaction Between Aging, Blood Pressure, and Sympathetic Nerve Activity , 2005, Hypertension.

[7]  P. Magni,et al.  Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin‐sensitivity, lipid profile and macronutrient preference , 2005, Clinical endocrinology.

[8]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[9]  M. Esler,et al.  Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation , 2004, Hypertension.

[10]  T. Ogihara,et al.  Serum Uric Acid and Plasma Norepinephrine Concentrations Predict Subsequent Weight Gain and Blood Pressure Elevation , 2003, Hypertension.

[11]  M. Rondon,et al.  Weight loss improves neurovascular and muscle metaboreflex control in obesity. , 2003, American journal of physiology. Heart and circulatory physiology.

[12]  M. Esler,et al.  Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy , 2003, Circulation.

[13]  M. Esler,et al.  Interactions Between Leptin and the Human Sympathetic Nervous System , 2003, Hypertension.

[14]  O. Vuolteenaho,et al.  Gender matters: estrogen protects from cardiac hypertrophy , 2003, Trends in Endocrinology & Metabolism.

[15]  D. Laude,et al.  Sympathetic and cardiac baroreflex function in panic disorder , 2002, Journal of hypertension.

[16]  S. Beske,et al.  Sympathetic Neural Activation in Visceral Obesity , 2002, Circulation.

[17]  C. Zoccali,et al.  Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease , 2002, Circulation.

[18]  M. Fischer,et al.  Renin angiotensin system and gender differences in the cardiovascular system. , 2002, Cardiovascular research.

[19]  John E. Hall,et al.  Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity , 2002, Hypertension.

[20]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[21]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[22]  V. Somers,et al.  Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects , 2001, Journal of hypertension.

[23]  Muscle sympathetic nerve activity and hemodynamic alterations in middle-aged obese women. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[24]  L. Landsberg.  Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why) , 2001, Journal of hypertension.

[25]  S. Engeli,et al.  Role of Adipose Tissue for Cardiovascular-Renal Regulation in Health and Disease , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[26]  G. Mancia,et al.  Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension , 2000, Hypertension.

[27]  D. Seals,et al.  Relation of leptin and insulin to adiposity-associated elevations in sympathetic activity with age in humans , 2000, International Journal of Obesity.

[28]  T. Ogihara,et al.  Sympathetic activity and body mass index contribute to blood pressure levels. , 2000, Hypertension research : official journal of the Japanese Society of Hypertension.

[29]  L. Hellström,et al.  Mechanisms behind gender differences in circulating leptin levels , 2000, Journal of internal medicine.

[30]  C. Delles,et al.  Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure. , 1999, American journal of hypertension.

[31]  A. Rantala,et al.  Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects , 1999, Journal of internal medicine.

[32]  C. Hinojosa-Laborde,et al.  GENDER DIFFERENCES IN SYMPATHETIC NERVOUS SYSTEM REGULATION , 1999, Clinical and experimental pharmacology & physiology.

[33]  C. Mantzoros,et al.  Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids. , 1998, American journal of physiology. Endocrinology and metabolism.

[34]  G. Mancia,et al.  Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. , 1998, Circulation.

[35]  G. Jennings,et al.  Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. , 1997, Circulation.

[36]  Y. Miyazaki,et al.  High plasma immunoreactive leptin level in essential hypertension. , 1997, American journal of hypertension.

[37]  A. Mark,et al.  Sympathetic and cardiorenal actions of leptin. , 1997, Hypertension.

[38]  E. Ravussin,et al.  Relationship between muscle sympathetic nerve activity and plasma leptin concentration. , 1997, Obesity research.

[39]  W. Garvey,et al.  The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. , 1997, The Journal of clinical endocrinology and metabolism.

[40]  S. Voyaki,et al.  Prevalence of obesity in Greek hypertensives. , 1996, Journal of human hypertension.

[41]  E. Ravussin,et al.  Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. , 1996, The American journal of physiology.

[42]  G. Mancia,et al.  Sympathetic activation in obese normotensive subjects. , 1995, Hypertension.

[43]  G. Jennings,et al.  Measurement of human sympathetic nervous responses to stressors by microneurography. , 1994, Journal of the autonomic nervous system.

[44]  P. Vollenweider,et al.  Body fat and sympathetic nerve activity in healthy subjects. , 1994, Circulation.

[45]  W. Kannel,et al.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. , 1986, American heart journal.

[46]  H. Halkin,et al.  Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. , 1985, The Journal of clinical investigation.

[47]  W. Kannel,et al.  Declining cardiovascular mortality. , 1984, Circulation.

[48]  W. Kannel,et al.  Optimal resources for primary prevention of atherosclerotic diseases. Atherosclerosis Study Group. , 1984, Circulation.

[49]  G. Jennings,et al.  Contribution of individual organs to total noradrenaline release in humans. , 1984, Acta physiologica Scandinavica. Supplementum.

[50]  B. Wallin,et al.  Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age , 1978, The Journal of physiology.

[51]  P. Vuorinen.  Obesity and the Heart , 1963, British medical journal.